ABL Bio에이비엘바이오
298380 · KOSDAQ · ₩298380 · 에이비엘바이오
₩41,800▲ ₩950 (2.33%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 16, 2026Open on DART
Predicted impact: Low
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 4, 2026Open on DART
- [Amended] Notice of Stock Purchase Option Grant[기재정정]주식매수선택권부여에관한신고Aug 31, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Aug 26, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 11, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 4, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (이중항체 면역항암제 ABL503의 제1상 임상시험계획 (IND) 변경승인)Jul 28, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 16, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (이중항체 면역항암제 ABL503의 제1상 임상시험계획 (IND) 변경승인)Jul 9, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 6, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jul 2, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jul 2, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jul 2, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (이중항체 면역항암제 ABL503의 제1상 임상시험계획 (IND) 변경승인 신청)Jun 9, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (이중항체 면역항암제 ABL503의 제1상 임상시험계획 (IND) 변경승인 신청)Jun 4, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 8, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 3, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Apr 1, 2026Open on DART
- Rights offering (paid-in capital increase) decision유상증자결정(종속회사의주요경영사항)Mar 30, 2026Open on DART
- Acquisition of shares in another company타법인주식및출자증권취득결정Mar 30, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 27, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 12, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 12, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 12, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 12, 2026Open on DART
- Audit report submitted감사보고서제출Mar 11, 2026Open on DART
- Exercise of Stock Purchase Options주식매수선택권행사Feb 11, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 6, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Feb 5, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jan 23, 2026Open on DART
- [Amended] Results of Securities Issuance (Voluntary Disclosure)[기재정정]증권발행결과(자율공시)Jan 16, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jan 16, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jan 9, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jan 9, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항 (GrabodyB 플랫폼 기술이전 및 공동개발 계약 체결)Jan 6, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jan 6, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jan 5, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Dec 26, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Dec 5, 2025Open on DART
- Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Nov 14, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Nov 13, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Nov 13, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Nov 13, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (Grabody-B 플랫폼 기술이전 및 공동개발 계약 체결)Nov 12, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 11, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Nov 11, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: ABL Bio / 에이비엘바이오 / 298380 / KRX:298380
Source: KRX statistical information